Arthritis and perceptions of quality of life: An examination of positive and negative affect in rheumatoid arthritis patients.

1995 ◽  
Vol 14 (5) ◽  
pp. 399-408 ◽  
Author(s):  
Alex J. Zautra ◽  
Mary H. Burleson ◽  
Craig A. Smith ◽  
Susan J. Blalock ◽  
Kenneth A. Wallston ◽  
...  
2000 ◽  
Vol 50 (4) ◽  
pp. 263-278 ◽  
Author(s):  
Rob Ranzijn ◽  
Mary Luszcz

There are two aims in this article, to define subjective quality of life and to suggest a way to standardize its measurement to enable comparisons to be made across studies. One of the unresolved issues in gerontological research has concerned the definition and measurement of quality of life (Lawton, 1991). This article focuses on subjective well-being, one of the four components proposed by Lawton (1991). There seems to be a growing consensus that most scales of well-being have at least two concepts in common, positive and negative affect. To test this hypothesis, two well-being scales, the Philadelphia Geriatric Center Morale Scale (Lawton, 1975) and the Center for Epidemiological Studies-Depression Scale (Radloff, 1977), were subjec ted to confirmatory factor analyses, using data on 1717 participants in the Australian Longitudinal Study of Ageing aged between 70 and 103 years. Each scale was shown to contain factors of positive and negative affect. The article concludes with a suggestion that the measurement of quality of life in elders should include, at a minimum, scales of positive and negative affect as well as other measures relevant to the aspect of quality of life under consideration.


2017 ◽  
Vol 1 (5) ◽  
pp. 7-9
Author(s):  
Abdul Saheer P ◽  
Tency Matthew Mariette ◽  
Shanila Abdul Majid

2020 ◽  
Vol 16 (3) ◽  
pp. 215-223
Author(s):  
Rostislav A. Grekhov ◽  
Galina P. Suleimanova ◽  
Andrei S. Trofimenko ◽  
Liudmila N. Shilova

This review highlights the issue of psychosomatic conditions in rheumatoid arthritis, paying special attention to new researches and trends in this field. Emerging concepts in all the major parts of the problem are covered consecutively, from the impact of chronic musculoskeletal pain on the emotional state to disease influence over quality of life, socio-psychological, and interpersonal relationships. Chronic pain is closely related to emotional responses and coping ability, with a pronounced positive effect of psychotherapeutic interventions, family and social support on it. Psychosexual disorders, anxiety, depression also commonly coexist with rheumatoid arthritis, leading to further decrease in quality of life, low compliance, and high suicide risk. Influence of psychosomatic conditions on the overall treatment effect is usually underestimated by rheumatologists and general practitioners. Psychosomatic considerations are of great importance for up-to-date management of rheumatoid arthritis, as they strongly influence the quality of life, compliance, and thereby disease outcomes. Two major approaches of psychological rehabilitation exist, both coping with pain through the regulation of emotion and psychotherapeutic intervention, which not only helps patients in coping with the disease, but also aimed at improving the overall adaptation of the patient. It includes techniques of relaxation, cognitive-behavioral therapy, and biofeedback therapy. Current data about the efficacy of the additional correcting therapies for patients with rheumatoid arthritis, both emerging and common ones, are discussed in the review.


2020 ◽  
Vol 16 ◽  
Author(s):  
Dalia S. Saif ◽  
Nagwa N. Hegazy ◽  
Enas S. Zahran

Background: Among rheumatoid arthritis patients (RA), general disease activity is well regulated by diseasemodifying anti-rheumatic medications (DMARDS), but sometimes local inflammation still persists among a few joints. Adjuvant modern molecular interventions as Platelet Rich Plasma (PRP) with a suggested down regulating effect on inflammatory mediators has a proven effect in management of RA. We aim to evaluate the therapeutic effect of intra-articular PRP versus steroid in RA patients and their impact on inflammatory cytokines IL1B , TNF α, local joint inflammation, disease activity and quality of life (QL). Methods: Open labeled parallel randomized control clinical trial was carried out on 60 RA patients randomly divided into 2 groups, Group 1: included 30 patients received 3 intra-articular injections of PRP at monthly interval, Group 2: included 30 patients received single intra-articular injection of steroid. They were subjected to clinical, laboratory, serum IL1B and TNF α assessment at baseline and at 3, 6 months post injection. Results: Patients of both groups showed improvements in their scores of evaluating tools at 3months post injection and this improvement was persistent in the PRP group up to 6 months post injection while it was continued only for 3 months in the steroid group. Conclusions: PRP is a safe, effective and useful therapy in treating RA patients who had insufficient response and persistent pain and inflammation in just one or two joints through its down regulating effect on inflammatory cytokines IL1B, TNF α with subsequent improvement of local joint inflammation, disease activity and QL.


Sign in / Sign up

Export Citation Format

Share Document